The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis

被引:150
|
作者
Kump, P. [1 ,2 ]
Wurm, P. [2 ,3 ]
Groechenig, H. P. [4 ]
Wenzl, H. [1 ]
Petritsch, W. [1 ]
Halwachs, B. [2 ,3 ,5 ]
Wagner, M. [1 ]
Stadlbauer, V. [1 ]
Eherer, A. [1 ]
Hoffmann, K. M. [6 ]
Deutschmann, A. [6 ]
Reicht, G. [7 ]
Reiter, L. [7 ]
Slawitsch, P. [7 ]
Gorkiewicz, G. [2 ,3 ,5 ]
Hoegenauer, C. [1 ,2 ,5 ]
机构
[1] Med Univ Graz, Dept Internal Med, Div Gastroenterol & Hepatol, Graz, Austria
[2] Med Univ Graz, Theodor Escherich Lab Med Microbiome Res, Graz, Austria
[3] Med Univ Graz, Inst Pathol, Graz, Austria
[4] Barmherzige Bruder Hosp, St Veit An Der Glan, Austria
[5] Interuniv Cooperat, BioTechMed Graz, Graz, Austria
[6] Med Univ Graz, Dept Pediat & Adolescent Med, Graz, Austria
[7] Barmherzige Bruder Hosp, Graz, Austria
基金
奥地利科学基金会;
关键词
EVIDENCE-BASED CONSENSUS; RNA GENE DATABASE; COMBINATION THERAPY; MAINTENANCE; REMISSION; COLONIZATION; METAANALYSIS; MANAGEMENT; INDUCTION; DIAGNOSIS;
D O I
10.1111/apt.14387
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundFaecal microbiota transplantation is an experimental approach for the treatment of patients with ulcerative colitis. Although there is growing evidence that faecal microbiota transplantation is effective in this disease, factors affecting its response are unknown. AimsTo establish a faecal microbiota transplantation treatment protocol in ulcerative colitis patients, and to investigate which patient or donor factors are responsible for the treatment success. MethodsThis is an open controlled trial of repeated faecal microbiota transplantation after antibiotic pre-treatment (FMT-group, n=17) vs antibiotic pre-treatment only (AB-group, n=10) in 27 therapy refractory ulcerative colitis patients over 90days. Faecal samples of donors and patients were analysed by 16SrRNA gene-based microbiota analysis. ResultsIn the FMT-group, 10/17 (59%) of patients showed a response and 4/17 (24%) a remission to faecal microbiota transplantation. Response to faecal microbiota transplantation was mainly influenced by the taxonomic composition of the donor's microbiota. Stool of donors with a high bacterial richness (observed species remission 94693 vs no response 797 +/- 181 at 15367rps) and a high relative abundance of Akkermansia muciniphila (3.3 +/- 3.1% vs 0.1 +/- 0.2%), unclassified Ruminococcaceae (13.8 +/- 5.0% vs 7.5 +/- 3.7%), and Ruminococcus spp. (4.9 +/- 3.5% vs 1.0 +/- 0.7%) were more likely to induce remission. In contrast antibiotic treatment alone (AB-group) was poorly tolerated, probably because of a sustained decrease of intestinal microbial richness. ConclusionsThe taxonomic composition of the donor's intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in ulcerative colitis patients. The design of specific microbial preparation might lead to new treatments for ulcerative colitis.
引用
收藏
页码:67 / 77
页数:11
相关论文
共 50 条
  • [1] A new compatibility test for donor selection for faecal microbiota transplantation in ulcerative colitis
    Ponce-Alonso, M.
    Garcia-Fernandez, S.
    Aguilera, L.
    Rodriguez-de-Santiago, E.
    Foruny, J. R.
    Roy, G.
    DelCampo, R.
    Canton, R.
    Lopez-Sanroman, A.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S480 - S481
  • [2] A new compatibility test for donor selection for faecal microbiota transplantation in ulcerative colitis
    Ponce-Alonso, M.
    Garcia-Fernandez, S.
    Aguilera, L.
    Rodriguez-de-Santiago, E.
    Foruny, J. R.
    Roy, G.
    DelCampo, R.
    Canton, R.
    Lopez-Sanroman, A.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S480 - S481
  • [3] Efficacy of combination therapy of fresh faecal microbiota transplantation and triple-antibiotic therapy for ulcerative colitis
    Ishikawa, D.
    Takahashi, M.
    Okahara, K.
    Ito, S.
    Haga, K.
    Shibuya, T.
    Osada, T.
    Nagahara, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S301 - S301
  • [4] Alterations of Intestinal Microbiota in Ulcerative Colitis Patients Treated with Sequential Antibiotic Combination and Faecal Microbiota Transplantation
    Ishikawa, D.
    Osada, T.
    Sasaki, T.
    Kuwahara-Arai, K.
    Haga, K.
    Shibuya, T.
    Kodani, T.
    Hiramatsu, K.
    Watanabe, S.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S364 - S365
  • [5] Predictors of non-response to repeated faecal microbiota transplantation in patients with therapy refractory ulcerative colitis
    Blesl, A.
    Rainer, F.
    Wurm, P.
    Durdevic, M.
    Petritsch, W.
    Wenzl, H.
    Baumann-Durchschein, F.
    Posch, A.
    Streit, A.
    Gorkiewicz, G.
    Groechenig, H. -P.
    Kump, P.
    Hoegenauer, C.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S412 - S412
  • [6] Oral faecal microbiota transplantation in ulcerative colitis reply
    Haifer, Craig
    Paramsothy, Sudarshan
    Kaakoush, Nadeem O.
    Leong, Rupert W.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (04): : 286 - 287
  • [7] Perceptions of faecal microbiota transplantation in patients with ulcerative colitis
    Chauhan, U. K.
    Popov, J.
    Kalantar, M.
    Wolfe, M.
    Moayyedi, P.
    Marshall, J. K.
    Halder, S.
    Kaasalainen, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S335 - S336
  • [8] Faecal Microbiota Transplantation refurbishes the crypt-associated microbiota in Ulcerative colitis
    Markandey, M.
    Bajaj, A.
    Verma, M.
    Virmani, S.
    Singh, M.
    Gaur, P.
    Das, P.
    Srikanth, C.
    Makharia, G.
    Kedia, S.
    Ahuja, V.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 1020 - 1022
  • [9] FAECAL MICROBIOTA TRANSPLANTATION REFURBISHES THE CRYPT-ASSOCIATED MICROBIOTA IN ULCERATIVE COLITIS
    Markandey, Manasvini
    Bajaj, Aditya
    Verma, Mehak
    Virmani, Shubi
    Singh, Mukesh K.
    Gaur, Preksha
    Das, Prasenjit
    Srikanth, Chittur V.
    Makharia, Govind K.
    Kedia, Saurabh
    Ahuja, Vineet
    GASTROENTEROLOGY, 2023, 164 (06) : S19 - S20
  • [10] Faecal microbiota transplantation (FMT) with dietary therapy for acute severe ulcerative colitis
    Costello, Samuel Paul
    Day, Alice
    Yao, Chu K.
    Bryant, Robert Venning
    BMJ CASE REPORTS, 2020, 13 (08)